Search Results

There are 12159 results for: content related to: Adalimumab may be better or no worse than methotrexate in the treatment of psoriasis

  1. Adalimumab for treating rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Federico Navarro-Sarabia, Rafael Ariza-Ariza, Blanca Hernandez-Cruz and Isidro Villanueva

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD005113.pub2

  2. You have free access to this content
    Adalimumab, a fully human anti–tumor necrosis factor α monoclonal antibody, for the treatment of rheumatoid arthritis in patients taking concomitant methotrexate: The ARMADA trial

    Arthritis & Rheumatism

    Volume 48, Issue 1, January 2003, Pages: 35–45, Michael E. Weinblatt, Edward C. Keystone, Daniel E. Furst, Larry W. Moreland, Michael H. Weisman, Charles A. Birbara, Leah A. Teoh, Steven A. Fischkoff and Elliot K. Chartash

    Article first published online : 10 JAN 2003, DOI: 10.1002/art.10697

  3. You have free access to this content
    The PREMIER study: A multicenter, randomized, double-blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment

    Arthritis & Rheumatism

    Volume 54, Issue 1, January 2006, Pages: 26–37, Ferdinand C. Breedveld, Michael H. Weisman, Arthur F. Kavanaugh, Stanley B. Cohen, Karel Pavelka, Ronald van Vollenhoven, John Sharp, John L. Perez and George T. Spencer-Green

    Article first published online : 29 DEC 2005, DOI: 10.1002/art.21519

  4. You have free access to this content
    Adalimumab for long-term treatment of psoriatic arthritis: Forty-eight week data from the adalimumab effectiveness in psoriatic arthritis trial

    Arthritis & Rheumatism

    Volume 56, Issue 2, February 2007, Pages: 476–488, Dafna D. Gladman, Philip J. Mease, Christopher T. Ritchlin, Ernest H. S. Choy, John T. Sharp, Peter A. Ory, Renee J. Perdok and Eric H. Sasso

    Article first published online : 30 JAN 2007, DOI: 10.1002/art.22379

  5. Newly Identified Antiatherosclerotic Activity of Methotrexate and Adalimumab: Complementary Effects on Lipoprotein Function and Macrophage Cholesterol Metabolism

    Arthritis & Rheumatology

    Volume 67, Issue 5, May 2015, Pages: 1155–1164, Nicoletta Ronda, Daniela Greco, Maria Pia Adorni, Francesca Zimetti, Elda Favari, Gunnbjørg Hjeltnes, Knut Mikkelsen, Maria Orietta Borghi, Ennio Giulio Favalli, Rita Gatti, Ivana Hollan, Pier Luigi Meroni and Franco Bernini

    Article first published online : 27 APR 2015, DOI: 10.1002/art.39039

  6. Rituximab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Maria Angeles Lopez-Olivo, Matxalen Amezaga Urruela, Lynda McGahan, Eduardo N Pollono and Maria E Suarez-Almazor

    Published Online : 20 JAN 2015, DOI: 10.1002/14651858.CD007356.pub2

  7. S3 – Guidelines on the treatment of psoriasis vulgaris (English version). Update

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue s2, March 2012, Pages: S1–s95, Alexander Nast, Wolf-Henning Boehncke, Ulrich Mrowietz, Hans-Michael Ockenfels, Sandra Philipp, Kristian Reich, Thomas Rosenbach, Adel Sammain, Martin Schlaeger, Michael Sebastian, Wolfram Sterry, Volker Streit, Matthias Augustin, Ricardo Erdmann, Joachim Klaus, Joachim Koza, Siegrid Muller, Hans-Dieter Orzechowski, Stefanie Rosumeck, Gerhard Schmid-Ott, Tobias Weberschock and Berthold Rzany

    Article first published online : 5 MAR 2012, DOI: 10.1111/j.1610-0387.2012.07919.x

  8. Biologics for rheumatoid arthritis: an overview of Cochrane reviews

    Overview of Reviews

    The Cochrane Library

    Jasvinder A Singh, Robin Christensen, George A Wells, Maria E Suarez-Almazor, Rachelle Buchbinder, Maria Angeles Lopez-Olivo, Elizabeth Tanjong Ghogomu and Peter Tugwell

    Published Online : 7 OCT 2009, DOI: 10.1002/14651858.CD007848.pub2

  9. Down-titration and discontinuation strategies of tumor necrosis factor–blocking agents for rheumatoid arthritis in patients with low disease activity

    Intervention Review

    The Cochrane Library

    Noortje van Herwaarden, Alfons A den Broeder, Wilco Jacobs, Aatke van der Maas, Johannes WJ Bijlsma, Ronald F van Vollenhoven and Bart(holomeus) JF van den Bemt

    Published Online : 29 SEP 2014, DOI: 10.1002/14651858.CD010455.pub2

  10. You have free access to this content
    Radiographic, clinical, and functional outcomes of treatment with adalimumab (a human anti–tumor necrosis factor monoclonal antibody) in patients with active rheumatoid arthritis receiving concomitant methotrexate therapy: A randomized, placebo-controlled, 52-week trial

    Arthritis & Rheumatism

    Volume 50, Issue 5, May 2004, Pages: 1400–1411, Edward C. Keystone, Arthur F. Kavanaugh, John T. Sharp, Hyman Tannenbaum, Ye Hua, Leah S. Teoh, Steven A. Fischkoff and Elliot K. Chartash

    Article first published online : 6 MAY 2004, DOI: 10.1002/art.20217

  11. Impact of adalimumab treatment on health-related quality of life and other patient-reported outcomes: results from a 16-week randomized controlled trial in patients with moderate to severe plaque psoriasis

    British Journal of Dermatology

    Volume 158, Issue 3, March 2008, Pages: 549–557, D. Revicki, M.K. Willian, J.-H. Saurat, K.A. Papp, J.-P. Ortonne, C. Sexton and A. Camez

    Article first published online : 28 NOV 2007, DOI: 10.1111/j.1365-2133.2007.08236.x

  12. A dose–response Meta-Analysis for Quantifying Relative Efficacy of Biologics in Rheumatoid Arthritis

    Clinical Pharmacology & Therapeutics

    Volume 90, Issue 6, December 2011, Pages: 828–835, J W Mandema, D H Salinger, S W Baumgartner and M A Gibbs

    Article first published online : 2 NOV 2011, DOI: 10.1038/clpt.2011.256

  13. You have free access to this content
    Effect of the early use of the anti–tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis

    Arthritis Care & Research

    Volume 59, Issue 10, 15 October 2008, Pages: 1467–1474, Victoria Bejarano, Mark Quinn, Philip G. Conaghan, Richard Reece, Anne-Maree Keenan, David Walker, Andrew Gough, Michael Green, Dennis McGonagle, Ade Adebajo, Stephen Jarrett, Sheelagh Doherty, Lesley Hordon, Richard Melsom, Kristina Unnebrink, Hartmut Kupper and Paul Emery

    Article first published online : 29 SEP 2008, DOI: 10.1002/art.24106

  14. You have free access to this content
    Clinical impact of concomitant immunomodulators on biologic therapy: Pharmacokinetics, immunogenicity, efficacy and safety

    The Journal of Clinical Pharmacology

    Volume 55, Issue S3, March 2015, Pages: S60–S74, Zhenhua Xu, Hugh M. Davis and Honghui Zhou

    Article first published online : 23 FEB 2015, DOI: 10.1002/jcph.380

  15. You have free access to this content
    Adalimumab for the treatment of patients with moderately to severely active psoriatic arthritis: Results of a double-blind, randomized, placebo-controlled trial

    Arthritis & Rheumatism

    Volume 52, Issue 10, October 2005, Pages: 3279–3289, Philip J. Mease, Dafna D. Gladman, Christopher T. Ritchlin, Eric M. Ruderman, Serge D. Steinfeld, Ernest H.S. Choy, John T. Sharp, Peter A. Ory, Renee J. Perdok and Mark A. Weinberg

    Article first published online : 30 SEP 2005, DOI: 10.1002/art.21306

  16. You have free access to this content
    Combination of adalimumab with traditional systemic antipsoriatic drugs – a report of 39 cases

    JDDG: Journal der Deutschen Dermatologischen Gesellschaft

    Volume 10, Issue 11, November 2012, Pages: 821–837, Sandra Philipp, Dagmar Wilsmann-Theis, Ansgar Weyergraf, Sebastian Rotterdam, Yvonne Frambach, Sascha Gerdes and Rotraut Mössner

    Article first published online : 31 AUG 2012, DOI: 10.1111/j.1610-0387.2012.07976.x

  17. You have full text access to this OnlineOpen article
    Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: Findings of a phase IIIb, multinational, prospective, randomized study

    Arthritis & Rheumatism

    Volume 65, Issue 1, January 2013, Pages: 28–38, Michael E. Weinblatt, Michael Schiff, Robert Valente, Désirée van der Heijde, Gustavo Citera, Cathy Zhao, Michael Maldonado and Roy Fleischmann

    Article first published online : 27 DEC 2012, DOI: 10.1002/art.37711

  18. A randomized, double-blind, placebo-controlled, phase III study of the human anti-tumor necrosis factor antibody adalimumab administered as subcutaneous injections in Korean rheumatoid arthritis patients treated with methotrexate

    APLAR Journal of Rheumatology

    Volume 10, Issue 1, April 2007, Pages: 9–16, Ho-Youn KIM, Soo-Kon LEE, Yeong Wook SONG, Dae-Hyun YOO, Eun-Mi KOH, Bin YOO and Allison LUO

    Article first published online : 8 MAR 2007, DOI: 10.1111/j.1479-8077.2007.00248.x

  19. Longitudinal Model-Based Meta-Analysis in Rheumatoid Arthritis: An Application Toward Model-Based Drug Development

    Clinical Pharmacology & Therapeutics

    Volume 92, Issue 3, September 2012, Pages: 352–359, I Demin, B Hamrén, O Luttringer, G Pillai and T Jung

    Article first published online : 4 JUL 2012, DOI: 10.1038/clpt.2012.69

  20. Tocilizumab for rheumatoid arthritis

    Intervention Review

    The Cochrane Library

    Jasvinder A Singh, Saba Beg and Maria Angeles Lopez-Olivo

    Published Online : 7 JUL 2010, DOI: 10.1002/14651858.CD008331.pub2